![Josias Fantato De Pontes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Josias Fantato De Pontes
Directeur Financier/CFO chez
SIGILON THERAPEUTICS, INC.
Profil
Josias Fantato De Pontes is currently the Treasurer, Chief Financial & Accounting Officer at Sigilon Therapeutics, Inc. He previously worked as the Senior Director-Accounting Reporting at Catalent JNP, Inc. from 2016 to 2018, the Senior Director-Rare Diseases Finance at Genzyme Corp.
from 2011 to 2015, and the Senior Director-Financial Planning & Analysis at Zafgen, Inc. from 2017 to 2019.
Mr. De Pontes holds an MBA from The Ohio University and an undergraduate degree from Fundação Escola de Comércio Álvares Penteado.
Postes actifs de Josias Fantato De Pontes
| Sociétés | Poste | Début |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Financier/CFO | 18/02/2022 |
Anciens postes connus de Josias Fantato De Pontes
| Sociétés | Poste | Fin |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | 31/08/2019 |
| JUNIPER PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2018 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Comptroller/Controller/Auditor | 01/05/2007 |
Formation de Josias Fantato De Pontes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fundação Escola de Comércio Álvares Penteado
 Fundação Escola de Comércio Álvares Penteado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
